OTC · PRPH

PROPHASE LABS Inc.

$0.06 +$0.00 (+1.03%) 1D After hours

Key Metrics

$206.45K
Market cap
P/E · TTM
$4.08M
Revenue · TTM
−$23.88M
Net income
EPS · TTM $-6.78
Dividend yield
Free cash flow
Beta · 1Y 1.51
EBITDA · TTM −$18.20M
Gross margin 28.2%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    From its Feb 9 high, the share price fell 67%.

    Peak close $0.18 on Feb 9; trough close $0.06 on Jul 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -67%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 23
    The stock moved +45.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 23
  • Mar 17
    The stock moved -28.0% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 17

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.05 – $1.84
Avg volume · 20D1.0M
Net cash
Book value / share$-0.12
ExchangeOTC
About PROPHASE LABS Inc.
IPO date
Employees

PROPHASE LABS INC

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S0.05
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross 28.2%
Operating -551.3%
Net -585.0%
FCF
ROE / ROIC 5,490.6% · 5,125.3%

Financial Health

Current ratio0.05
Quick ratio0.05
Debt / equity
Debt / EBITDA
Net cash
Working capital−$52.82M

Cash Flow · TTM

Operating CF −$5.71M
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

1 / 9
Weak fundamentals · 1 of 9 signals passing

Altman Z-Score

-4.2
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings